Radiation response enhanced by inhibition of XPO1 in preclinical rectal cancer models

被引：4
|
作者：
von Fallois, Moritz [1 ]
Depping, Reinhard [1 ]
机构：
[1] Univ Lubeck, Inst Physiol, Ratzeburger Allee 160, D-23562 Lubeck, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2016年 / 192卷 / 12期
关键词：
D O I：
10.1007/s00066-016-1060-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：961 / 962
页数：2
相关论文
共 50 条
  • [31] Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancer
    Sendino, Maria
    Josu Omaetxebarria, Miren
    Antonio Rodriguez, Jose
    CANCER DRUG RESISTANCE, 2018, 1 (03) : 139 - 163
  • [32] XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
    Giovanni Luca Gravina
    Monica Tortoreto
    Andrea Mancini
    Alessandro Addis
    Ernesto Di Cesare
    Andrea Lenzi
    Yosef Landesman
    Dilara McCauley
    Michael Kauffman
    Sharon Shacham
    Nadia Zaffaroni
    Claudio Festuccia
    Journal of Hematology & Oncology, 7
  • [33] Targeting the undruggable MYC in cancer: the rationale of using XPO1 inhibitors
    Leonidas Benetatos
    Eleftheria Hatzimichael
    Eleni Kapsali
    Molecular Biology Reports, 2025, 52 (1)
  • [34] XPO1 and BRAF Inhibition Synergize and Modulate pRb, Survivin and ERK in Melanoma
    Fragomeni, R. A. Salas
    Cusack, J. C.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S91 - S91
  • [35] Radiation response in preclinical orthotopic models of brain cancer
    Trachet, Erin E.
    Urs, Sumithra
    Wong, Alden
    Wise, Scott
    Franklin, Maryland Rosenfeld
    CANCER RESEARCH, 2019, 79 (13)
  • [36] Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
    Quintanal-Villalonga, Alvaro
    Taniguchi, Hirokazu
    Hao, Yuan
    Chow, Andrew
    Zhan, Yingqian A.
    Chavan, Shweta S.
    Uddin, Fathema
    Allaj, Viola
    Manoj, Parvathy
    Shah, Nisargbhai S.
    Chan, Joseph M.
    Offin, Michael
    Ciampricotti, Metamia
    Ray-Kirton, Jordana
    Egger, Jacklynn
    Bhanot, Umesh
    Linkov, Irina
    Asher, Marina
    Roehrl, Michael H.
    Qiu, Juan
    de Stanchina, Elisa
    Hollmann, Travis J.
    Koche, Richard P.
    Sen, Triparna
    Poirier, John T.
    Rudin, Charles M.
    CANCER RESEARCH, 2022, 82 (03) : 472 - 483
  • [37] XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a
    Wang, Jingya
    Sun, Tao
    Meng, Zhaoting
    Wang, Liuchun
    Li, Mengjie
    Chen, Jinliang
    Qin, Tingting
    Yu, Jiangyong
    Zhang, Miao
    Bie, Zhixin
    Dong, Zhiqiang
    Jiang, Xiangli
    Li Lin
    Zhang, Cuicui
    Liu, Zhujun
    Jiang, Richeng
    Yang, Guang
    Li, Lin
    Zhang, Yan
    Huang, Dingzhi
    CANCER LETTERS, 2021, 503 : 197 - 212
  • [38] Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
    Sexton, Rachel
    Mahdi, Zaid
    Chaudhury, Rahman
    Beydoun, Rafic
    Aboukameel, Amro
    Khan, Husain Y.
    Baloglu, Erkan
    Senapedis, William
    Landesman, Yosef
    Tesfaye, Anteneh
    Kim, Steve
    Philip, Philip A.
    Azmi, Asfar S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [39] Autophagy modulates glioblastoma cell sensitivity to Selinexor-mediated XPO1 inhibition
    Tang, Yongjian
    Sprinzen, Lisa
    Terada, Yukinori
    Kiang, Karrie M.
    Li, Chuntao
    Zeng, Yu
    Liu, Fangkun
    Zhou, Hongshu
    Liang, Xisong
    Zhang, Jianzhong
    Pieper, Russell O.
    Chen, Bo
    Zhang, Liyang
    NEURO-ONCOLOGY, 2025,
  • [40] The STK38–XPO1 axis, a new actor in physiology and cancer
    Alexandre PJ. Martin
    Vasily N. Aushev
    Gérard Zalcman
    Jacques H. Camonis
    Cellular and Molecular Life Sciences, 2021, 78 : 1943 - 1955
12345